A new trading day began on Monday, with Iovance Biotherapeutics Inc (NASDAQ: IOVA) stock price down -1.02% from the previous day of trading, before settling in for the closing price of $1.97. IOVA’s price has ranged from $1.64 to $12.51 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 4.17% over the last five years. Meanwhile, its annual earnings per share averaged 10.58%. With a float of $292.67 million, this company’s outstanding shares have now reached $341.92 million.
Iovance Biotherapeutics Inc (IOVA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Iovance Biotherapeutics Inc is 19.12%, while institutional ownership is 53.81%. The most recent insider transaction that took place on Jun 05 ’25, was worth 55,200. In this transaction Chief Commercial Officer of this company bought 30,000 shares at a rate of $1.84, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 23 ’25, when Company’s Chief Regulatory Officer bought 5,600 for $1.74, making the entire transaction worth $9,743. This insider now owns 206,852 shares in total.
Iovance Biotherapeutics Inc (IOVA) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.28 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 10.58% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.46% during the next five years compared to 4.17% growth over the previous five years of trading.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Trading Performance Indicators
Here are Iovance Biotherapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Iovance Biotherapeutics Inc (IOVA)
Analysing the last 5-days average volume posted by the [Iovance Biotherapeutics Inc, IOVA], we can find that recorded value of 21.8 million was better than the volume posted last year of 13.33 million. As of the previous 9 days, the stock’s Stochastic %D was 10.69%.
During the past 100 days, Iovance Biotherapeutics Inc’s (IOVA) raw stochastic average was set at 10.86%, which indicates a significant decrease from 16.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1436 in the past 14 days, which was lower than the 0.1868 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.2174, while its 200-day Moving Average is $2.9990. Now, the first resistance to watch is $2.1467. This is followed by the second major resistance level at $2.3433. The third major resistance level sits at $2.4867. If the price goes on to break the first support level at $1.8067, it is likely to go to the next support level at $1.6633. Now, if the price goes above the second support level, the third support stands at $1.4667.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Key Stats
With a market capitalization of 705.61 million, the company has a total of 361,854K Shares Outstanding. Currently, annual sales are 164,070 K while annual income is -372,180 K. The company’s previous quarter sales were 59,950 K while its latest quarter income was -111,660 K.
